Guangzhou Biotron Technology Co., Ltd.

Guangzhou Biotron Technology Co., Ltd. specializes in in vitro diagnostic (IVD) kits designed for nucleic acid detection. Their products use fluorescent PCR melting curve methods to identify specific genetic markers, including human papillomavirus (HPV) genotypes (such as HPV 15 and HPV 31) and E6/E7 mRNA variants. They also offer respiratory pathogen detection kits that identify 12 or 15 different pathogens simultaneously. These devices are intended for laboratory use to aid in diagnosing infections or genetic conditions.

Guangzhou Biotron Technology Co., Ltd. is based in China. While the company’s headquarters location influences its domestic regulatory compliance, its IVD devices are listed in the EU’s eudamed registry, indicating they are registered under EU regulations. This means the devices must meet EU requirements for safety, performance, and traceability, even though the manufacturer itself is not EU-approved—only its individual devices are authorised for use in the EU market.

The devices produced by Guangzhou Biotron Technology Co., Ltd. fall under the IVD General classification. This classification applies to in vitro diagnostics that do not pose significant risks (e.g., low-risk devices like nucleic acid detection kits for genotyping or pathogen screening). The classification determines the regulatory pathway for authorisation, ensuring these products undergo appropriate scrutiny for safety and clinical performance without the stricter requirements of higher-risk IVDs.

The devices manufactured by Guangzhou Biotron Technology Co., Ltd. are listed in the eudamed registry, which is the EU’s centralised database for medical devices. This inclusion is important because it provides transparency on the device’s registration status within the EU, allowing healthcare professionals, regulators, and authorities to verify compliance with EU regulations. Listing in eudamed ensures traceability and helps streamline market surveillance, though it does not imply the company itself is approved—only that its devices meet the necessary criteria for authorised use in the EU.